Latest Breaking News On - Regenxbio inc united states - Page 1 : comparemela.com

Viral Vector Market was worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 billion USD by 2029.

Western capeSouth africaUnited statesSouth koreaUnited kingdomRegenxbio inc united statesSarepta therapeutics incBiogen incResearch organisationsMeiragtx holdingsKrystal biotech incThermo fisher scientific incPfizer incMarket researchAstellas pharma incMarket research is india